Pricing
Not listed
Official monthly price not confirmed
- API
- Not confirmed
Research · Vendor site 2026-10-04
Panacea pairs an ex-FDA regulatory team with an in-house AI platform to accelerate FDA submissions across 510(k), De Novo, PMA, IND, NDA, and BLA pathways. The service emphasizes milestone-based fixed pricing, expert oversight, and faster outputs than traditional consulting firms.
Medtech and biotech sponsors that need FDA regulatory strategy and filing support with AI-assisted delivery.
Homepage invites consultations and describes fixed milestone pricing rather than listing public monthly software tiers.
Panacea blends specialized AI tooling with former FDA experts to move regulatory filings faster under fixed milestone engagements.
What it can do
Unknown is different from unavailable. Each fact carries its own evidence.
| Capability | Value | Evidence | Checked |
|---|---|---|---|
| Pathways | Homepage states support across 510(k), De Novo, PMA, IND, NDA, and BLA FDA approval pathways. | Facts sourced | 2026-10-04 |
| Team composition | Copy combines ex-FDA regulatory experts with AI engineers and claims 100% oversight by experts. | Facts sourced | 2026-10-04 |
| Pricing model | Marketing highlights milestone-based fixed pricing aligned with sponsor development cycles. | Facts sourced | 2026-10-04 |
Understand the total cost
Pricing
Not listed
Official monthly price not confirmed
Search Atlas, including OTTO SEO automation, is an AI marketing platform for SEO, content, PPC, and site audits with autonomous fixes across channels. Subscription plans scale from single-brand Starter use through agency portfolios with execution budgets and onboarding support.
Explore toolOrimon.ai is a no-code platform for building generative AI chatbots that automate support, qualify leads, and answer internal questions across websites, WhatsApp, Instagram, and other channels. It advertises multilingual support, analytics, live-agent handoff, and integrations such as HubSpot.
Explore toolEnago Read (formerly RAxter) is an AI literature-review workspace for researchers. It summarizes papers section by section, surfaces key insights, finds related literature from a large database, and adds a Copilot chat mode for deeper paper Q&A and collaboration.
Explore toolThe practical questions
Panacea pairs an ex-FDA regulatory team with an in-house AI platform to accelerate FDA submissions across 510(k), De Novo, PMA, IND, NDA, and BLA pathways. The service emphasizes milestone-based fixed pricing, expert oversight, and faster outputs than traditional consulting firms.
Not confirmed. This record does not confirm an ongoing free plan.
A listed monthly price has not been confirmed. See the plan cards for entitlements, billing commitments and seat minimums.
Not confirmed. API access and subscription access may have different terms; consult the linked sources.
Homepage invites consultations and describes fixed milestone pricing rather than listing public monthly software tiers.
No retained pricing changes yet. A current price alone does not establish a historical trend.
Reviewed vendor source
Read original source ↗Facts apply to the named version and check date. Send a sourced correction if something changed.